An apparatus includes a blood-flow-management assembly shaped to define a cylindrical aperture. The blood-flow-management assembly includes a blood collector having drainage holes configured to direct blood to a guide surface positioned below the blood collector. The guide surface may further include ribs that manage blood flow along the guide surface.

Provide is a blood collection container capable of suppressing the occurrence of blood clots involving bubbles when blood containing heparin is coagulated, and capable of suppressing the production of fibrin in serum after separation when blood containing heparin is separated into serum and blood clots. A blood collection container according to the present invention includes: a blood collection container main body having an opening at one end thereof and a closed bottom at the other end thereof; a serine protease disposed in the blood collection container main body; and a heparin neutralizing agent disposed in the blood collection container main body, wherein when a region in which the serine protease is disposed is defined as a first region, and a region in which the heparin neutralizing agent is disposed is defined as a second region, the second region includes a region present on an other end side with respect to an end on the other end side of the first region.

An interface device between external equipment and at least a venous tube for transferring fluid to a patient, the interface device having at least a first port adapted to be connected to an outlet port of the external equipment; and a venous port carried by a stator of the interface device in order to inject the fluid into the venous tube. The interface device includes a third port, the first port and the third port being carried by a movable assembly that is movable relative to the stator, the interface device being arranged to pass from any one of its configurations to another one of its configurations by the movable assembly moving relative to the stator.

The present disclosure relates to devices, e.g, extracorporeal blood purification (EBP) devices, which comprise a cartridge or sorbent comprising a cellular membrane derived from a cell. The present disclosure also relates methods for removing or reducing a substance, e.g, an undesirable substance, from a fluid, e.g, a subject’s blood, using the devices or EBP devices.

A medical device is adapted for use in assisting with mechanical thrombectomy. The medical device may include a housing that is adapted to be held within a user's hand and a pump that is secured within the housing. A fluid inlet is adapted to receive fluid that is pulled towards the pump and is fluidly coupled with the pump. A fluid outlet is adapted to expel fluid away from the pump and is fluidly coupled with the pump. As the pump is operated by the user, fluid is alternatively pulled into the fluid inlet and expelled through the fluid outlet. In some cases, the fluid may be blood or other bodily fluids.

An embodiment provides a method for treating a body fluid of a patient with Alzheimer's Disease, including: removing the body fluid from a patient; applying a treatment to the body fluid, wherein the treatment comprises an antibody that joins with an Alzheimer's targeted antigen (TA) in the body fluid to form an antibody-TA complex, wherein the antibody comprises a tag sensitive to an illumination; removing the antibody-TA complex from the body fluid using an illumination source; and returning the body fluid to the patient. Other aspects are described and claimed.

Systems, devices, and methods are provided for sensing gas bubbles within a liquid flow line, such as within a medical device. The systems, devices, and methods can measure a change in capacitance across a pair of conductive plates to calculate a volume of gas in a flow line. If a calculated volume of gas exceeds an established threshold, an alert can be sent and/or changes made to operation of the device.

A cannula for minimally invasive surgical tricuspid valve repair, which is constituted by a tube (5). equipped, at its distal end. with a head (2) consisting of a cone-shaped rigid ring (3) and connected to it on the other side of a flexible ring (4). where the flexible ring (4) in the folded state has a disk shape, and on top of the head (2) there is an axial hole (8) leading to the interior of the cannula (1). and where on the whole length of the head (2) and on a part of the tube (5) near the connection to the head (2), from the inside, there is a thin guide sleeve (6) which, on the section of the rigid ring (3) is permanently attached to the surface of its wall, while on its remaining length, it is slidably movable relative to the wall of the tube (5).

The disclosed device, systems and methods relate to a novel catheter, system and methods. Exemplary embodiments comprise a plurality of lumens and balloons for insertion into the aorta and vena cava.

A process for removing Sr.sup.2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula:
A.sub.mZr.sub.aTi.sub.bSn.sub.cM.sub.dSi.sub.xO.sub.y. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.